Non-classical antimetabolites—VIII. The bridge principle of specificity with exo-alkylating irreversible inhibitors
- 1 December 1962
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 11 (12) , 1155-1161
- https://doi.org/10.1016/0006-2952(62)90194-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Potential Anticancer Agents. LXXVIII.1 Nonclassical Antimetabolites. IV.2 Synthesis of Compounds Related to 4-(Iodoacetamido)salicylic Acid, an Exo-Alkylating Irreversible InhibitorThe Journal of Organic Chemistry, 1962
- Analogs of Tetrahydrofolic Acid VI.Journal of Pharmaceutical Sciences, 1962
- Modification of a Methionine Residue Near the Active Site of ChymotrypsinJournal of the American Chemical Society, 1962
- Non-classical Antimetabolites. VII.1,2 The Bridge Principle of Specificity with Exo-alkylating Irreversible InhibitorsJournal of Medicinal Chemistry, 1962
- Structural Characteristics of Dehydrogenases*Biochemistry, 1962
- POTENTIAL ANTICANCER AGENTS.1 LXVI. NON-CLASSICAL ANTIMETABOLITES. III.2 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASEJournal of the American Chemical Society, 1961
- Potential Anticancer Agents --L. Non-Classical Antimetabolites--II. Some Factors in the Design of Exo-Alkylating Enzyme Inhibitors, partcularly of Lactic DehydrogenaseJournal of Medicinal Chemistry, 1960
- ANTIBODIES AGAINST ENZYMESAnnual Review of Microbiology, 1957
- IMMUNOLOGICAL DIFFERENCES OF PHOSPHORYLASESJournal of Biological Chemistry, 1957